Exeltis is part of the Spanish multinational Insud Pharma, which has a track record of over 40 years and a team of 7,000 professionals worldwide. Insud Pharma is present at every level of the chemical and pharmaceutical industry through its three highly-synergistic business units: industrial (Chemo), brand (Exeltis) and biotechnology (mAbxience). Our overarching goal is to protect and improve people’s health and wellbeing.
Exeltis is a leader in the field of Women's Health. It researches, innovates and creates new treatments and devices to improve the health and wellbeing of women all over the world. With a global footprint spanning more than 40 countries, Exeltis has a team of over 4,000 professionals and a global manufacturing network. Exeltis has one overarching goal: to offer women support and care throughout every single stage of their lives.
We offer a broad range of products to respond to women's needs in the areas of fertility, reproductive health, contraception, pregnancy, childbirth and menopause. In recent years, we have diversified our portfolio to include the central nervous system.